Advertisement
NorthEastern
NorthEastern

Tobacco Company Versus Academia

The makers of Marlboro cigarettes are asking researchers at a Scottish university to disclose data on children’s thoughts on tobacco marketing.

By | September 6, 2011

DREAMSTIME, MAGDALENA ZURAWSKA

Researchers at the University of Stirling in Scotland are embroiled in a fight against tobacco giant Philip Morris International (the maker of Marlboro cigarettes) over data University researchers collected on children’s and teens’ attitudes toward smoking and cigarette packaging. The company has submitted two Freedom of Information (FOI) requests for access to all the raw data collected by Stirling’s Centre for Tobacco Control Research, which includes interviews with over 5,500 youngsters aged between 11 and 16.

"They wanted everything we had ever done on this," Gerard Hastings, the institute's director, told The Independent. "These are confidential comments about how youngsters feel about tobacco marketing. This is the sort of research that would get a tobacco company into trouble if it did it itself."

Philip Morris International had originally submitted a request for the information anonymously through a London law firm in September 2009, but was rejected on account of the anonymity. However, the Scottish information officer in charge of the case has ruled the University must respond to the two latest requests, The Guardian reports.

Although the identity of the studies’ participants will remain confidential, Hastings fears that handing over the data will have several negative repercussions for the Centre’s world-renowned research on tobacco use. For example, it might discourage future volunteers from participating and sharing personal information with the researchers. It might also make researchers in other institutions weary of sharing their data.

“Our funders will have to think carefully about the further funding of our research," Hastings told The Independent. “I don't think for one moment a cancer charity is going to take kindly to paying us hundreds of thousands of pounds to give aid and succour to a multinational tobacco corporation.” (Hat tip to The Chronicle)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Chris MacDonald

Chris MacDonald

Posts: 1457

September 6, 2011

Any well-conducted consent process makes certain promises to research participants about the goals of the research and about who will have access to raw data. For the researchers here to keep those promises is not just permissible, it is obligatory.

I blogged about this from an ethics point of view, here:http://www.canadianbusiness.co...

Avatar of:

Posts: 0

September 6, 2011

Any well-conducted consent process makes certain promises to research participants about the goals of the research and about who will have access to raw data. For the researchers here to keep those promises is not just permissible, it is obligatory.

I blogged about this from an ethics point of view, here:http://www.canadianbusiness.co...

Avatar of:

Posts: 0

September 6, 2011

Any well-conducted consent process makes certain promises to research participants about the goals of the research and about who will have access to raw data. For the researchers here to keep those promises is not just permissible, it is obligatory.

I blogged about this from an ethics point of view, here:http://www.canadianbusiness.co...

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
Gilson
Gilson
Advertisement
RayBioTech